Ideal marker for targeted axillary dissection (IMTAD): a prospective multicentre trial

Ideal marker for targeted axillary dissection (IMTAD): a prospective multicentre trial

Abstract Background Targeted axillary dissection (TAD) is an established method for axillary staging in patients with breast cancer after neoadjuvant chemotherapy (NAC). TAD consists of sentinel lymph node biopsy and initially pathological lymph node excision, which must be marked by a reliable mark...

Full description

Bibliographic Details
Main Authors: Jan Žatecký, Oldřich Coufal, Ondřej Zapletal, Otakar Kubala, Markéta Kepičová, Adéla Faridová, Karel Rauš, Jiří Gatěk, Peter Kosáč, Matúš Peteja
Format: Article
Language:English
Published: BMC 2023-08-01
Series:World Journal of Surgical Oncology
Subjects:
Targeted axillary dissection
Breast cancer
Magnetic seed
Iodine seed
Clip
Carbon suspension
Online Access:https://doi.org/10.1186/s12957-023-03147-x

Internet

https://doi.org/10.1186/s12957-023-03147-x

Similar Items